Shijun Kang
253 Gongye Road
Guangzhou, 510282, China
Guangzhou, 510282, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Lymphopenic condition enhanced the antitumor immunity of PD-1-knockout T cells mediated by CRISPR/Cas9 system in malignant melanoma.
Journal: Immunology letters
Published: July 26, 2022
Interleukin-12 over-expression in malignant melanoma B16 cells reduces programmed death-1 expression on T cells in mice with immune reconstitution
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: September 08, 2020
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 22, 2020
Soluble PD-1 over-expression enhances the anti-tumor effect of senescence tumor cell vaccine against breast cancer cell growth in tumor-bearing mice
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: January 30, 2018
Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells.
Journal: Cancer science
Published: December 12, 2017
Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 26, 2017
Small interfering RNA (siRNA)-mediated knockdown of Notch1 suppresses tumor growth and enhances the effect of IL-2 immunotherapy in malignant melanoma.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: February 09, 2016
A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response.
Journal: Cancer immunology, immunotherapy : CII
Published: December 04, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026